share_log

Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $216

Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $216

Keybanc维持对重症监护病房医疗的增持,将目标股价上调至216美元
Benzinga ·  2023/05/09 05:27

Keybanc analyst Matthew Mishan maintains ICU Medical (NASDAQ:ICUI) with a Overweight and raises the price target from $200 to $216.

Keybanc分析师马修·米山维持ICU Medical(纳斯达克股票代码:ICUI)的增持,并将目标股价从200美元上调至216美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发